Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Starch and Chemical Company was a prominent global producer of specialty starches, polymers, and adhesives, with a significant footprint in the life sciences and pharmaceutical industries. The company provided critical pharmaceutical excipients, such as disintegrants and binders, which are essential for the formulation of solid oral dosage drugs. Additionally, its nutritional division developed resistant starches and specialty carbohydrates used in clinical nutrition and weight management. In 2010, the company's specialty starch business was acquired by Corn Products International (now Ingredion), while its adhesives and electronic materials businesses were acquired by Henkel. Today, its legacy products continue to be widely used in the pharmaceutical and food science sectors under the Ingredion brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Starch and Chemical Company.